<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01955330</url>
  </required_header>
  <id_info>
    <org_study_id>Kiaii-LTFUP-Hybrid-2013</org_study_id>
    <secondary_id>REB #15000</secondary_id>
    <nct_id>NCT01955330</nct_id>
  </id_info>
  <brief_title>Long Term Follow-up Hybrid Revascularization</brief_title>
  <official_title>Long Term Follow-up of Robotic Hybrid Surgical Revascularization With CT Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>London Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      OBJECTIVES:

      The objectives of the year study are two-fold:

        1. To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft
           and stent of patients who have already had robotically-assisted Hybrid CABG surgery
           using CTA and MPS-MIBI.

        2. To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG
           surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      New techniques such as robotically-assisted Hybrid CABG surgery need proper evaluation to
      ensure potential benefits gained are not harmful to that which we know to be of significant
      benefit to the patients, that being the left internal thoracic artery (LITA) graft (one of
      the main coronary arteries supplying your heart with blood). We are therefore proposing a 5-7
      year CT-Angiography (CTA) and Myocardial Perfusion Scintigraphy (MPS-MIBI) to assess the
      patency rate of the LITA graft and the stented graft in patients that have already undergone
      robotically assisted Hybrid CABG.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Graft patency</measure>
    <time_frame>5-7 years post Hybrid surgery</time_frame>
    <description>To assess the graft patency of the LITA to LAD performed by the robot and the patency of the Stent.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Hybrid robotic cabg patients</arm_group_label>
    <description>Postoperative (5-7 years)Hybrid CABG robotically assisted surgical revascularization patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic Hybrid coronary artery revascularization</intervention_name>
    <description>Lita to LAD performed by robot, Hybrid stent to other diseased coronary artery</description>
    <arm_group_label>Hybrid robotic cabg patients</arm_group_label>
    <other_name>Robotic Hybrid CABG</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that have previously had Hybrid robotic coronary artery revascularization
        performed approximately 5-7 years ago at the London Health Sciences Centre, University
        Hospital by Dr. Kiaii.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients that have previously had Hybrid robotic coronary artery revascularization
        performed approximately 5-7 years ago at the London Health Sciences Centre, University
        Hospital by Dr. Kiaii.

        Exclusion Criteria:

        - Patients not described above
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bob Kiaii, MD</last_name>
    <phone>519-685-8500</phone>
    <phone_ext>33153</phone_ext>
    <email>Bob.Kiaii@lhsc.on.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephanie Fox, RRT</last_name>
    <phone>519-685-8500</phone>
    <phone_ext>35031</phone_ext>
    <email>Stephanie.Fox@lhsc.on.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>London Health Sciences Centre, University &amp; Victoria Hospitals</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joe Gilbert, MD</last_name>
      <phone>519-661-2111</phone>
    </contact>
    <investigator>
      <last_name>Jonathan Romsa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Burns, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Fox, RRT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cigdem Akincioglu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Luc Urbain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bob Kiaii, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2013</study_first_submitted>
  <study_first_submitted_qc>September 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2013</study_first_posted>
  <last_update_submitted>September 27, 2013</last_update_submitted>
  <last_update_submitted_qc>September 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Bob Kiaii</investigator_full_name>
    <investigator_title>Chair/ Chief Cardiac Surgery</investigator_title>
  </responsible_party>
  <keyword>CABG, Hybrid, Robotic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

